Canadian application, no grantCanada
Product comprising at least a double stranded rna combined with at least an antiviral agent
CA 2299554 A1 · Owner: Ipsen Pharma S.A.S · Inventors: Deschamps De Paillette, Evelyne
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns a product comprising at least a double stranded RNA (RNAdb) combined with at least an antiviral agent for therapeutic use in the treatment of a viral disease in particular different types of hepatitis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 3, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 3, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 3, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 3, 1998
GrantedNo grant recorded
Term endedAugust 3, 2018
Patent numberCA 2299554 A1
Classification (IPC)A61K38/21
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.